Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observational study.

Jensen, Anders Boisen et al.·BMC endocrine disorders·2025·
RPEP-115842025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observational study.
Published In:
BMC endocrine disorders, 25(1), 93 (2025)
Database ID:
RPEP-11584

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-11584·https://rethinkpeptides.com/research/RPEP-11584

APA

Jensen, Anders Boisen; Machado, Ursina; Renström, Frida; Aczél, Stefan; Folie, Patrick; Biraima-Steinemann, Magdalena; Bilz, Stefan. (2025). Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observational study.. BMC endocrine disorders, 25(1), 93. https://doi.org/10.1186/s12902-025-01913-4

MLA

Jensen, Anders Boisen, et al. "Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observational study.." BMC endocrine disorders, 2025. https://doi.org/10.1186/s12902-025-01913-4

RethinkPeptides

RethinkPeptides Research Database. "Efficacy of 12 months therapy with glucagon-like peptide-1 r..." RPEP-11584. Retrieved from https://rethinkpeptides.com/research/jensen-2025-efficacy-of-12-months

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.